Estimation of rPSGL-Ig doses in humans that provide exposure equal to those observed in different animal disease models
↵3-a Predicted doses that will provide equal AUC of rPSGL-Ig in human as in animals treated with doses shown in column 3.
↵3-b Predicted doses that will provide equalCmax of rPSGL-Ig in human as in animals treated with doses shown in column 3.